HYPER-CONVERGED INFRASTRUCTURE, APPLICATION STORAGE
businesswire | March 23, 2023
H5 Data Centers, a national colocation and wholesale data center provider, broke ground yesterday in Ashburn, VA on a strategically-located, state-of-the-art data center. Upon completion, the three-story data center will support 42 MWs of critical load across 255,000 square feet.
Today's announcement responds to accelerating demand for large-scale data center space in top-tier markets. Pre-leasing is under way with availability in Q3 of 2024. The data center located on Beaumeade Circle will qualify for Virginia data center sales and use tax exemption.
“H5 Data Centers is investing extensively across our portfolio and today's announcement of our Ashburn groundbreaking is an exciting start to a busy year of development,” said Josh Simms, founder and CEO of H5 Data Centers. “Upon completion, the data center will provide our customers with the ability to meet their stringent security and reliability requirements.”
Northern Virginia is the largest data center market in the world, but the immense growth of the market has made it difficult for cloud and technology companies to source scalable capacity. The build represents a high-quality option for cloud service providers, content and technology companies, and Fortune 500 customers alike.
About H5 Data Centers
H5 Data Centers is one of the leading privately-owned data center operators in the United States with over 3 million square feet of data center space under management. The company designs and engineers flexible and scalable data center solutions to address the core infrastructure and edge requirements of its customers. H5 Data Centers operates data centers in 20 US markets.
Read More
HYPER-CONVERGED INFRASTRUCTURE, APPLICATION STORAGE
Oxford Quantum Circuits | March 15, 2023
On March 14, 2023, Oxford Quantum Circuits (OQC), an industry-leading global quantum computing as a service (QCaaS) provider company, and the world's digital infrastructure provider, Equinix, announced that OQC aims make one of the world's most powerful commercially available quantum computers to via Equinix's TY11 Tokyo International Business Exchange data center.
The technology is intended to benefit a wide range of industries, including drug discovery and development, banking, risk management, and advanced manufacturing. Once connected to Equinix Fabric, organizations will have access to quantum computing as if it were on-premises, allowing them to trial and experiment with the innovative technology by connecting directly to QCaaS within their own digital infrastructure with improved security and ease.
Dr. Ilana Wisby, CEO at OQC ltd., stated, "The world has been waiting for quantum computing to mature to the point that it can change our lives. Installing quantum computing in Equinix's world-class TY11 data center brings us a step closer to this reality. Quantum computing represents a major shift in terms of technology and process. Unlike traditional classical computers, quantum computers can crunch vast amounts of data at incredible speeds. We are excited to work with Equinix to help businesses around the world to build their quantum skillset and capabilities. The future is here, and we are setting the pace for the era of quantum computing."
(Source – Cision PR Newswire)
Arun Dev, Global Head of Digital Interconnection at Equinix, remarked, "Quantum computing has the potential to transform the way businesses solve problems both now and into the future, especially as our customers look for more innovative solutions. As the world's digital infrastructure company, we are proud to enable easier, secure, high-bandwidth access to this pioneering technology to thousands of businesses around the world. Welcoming OQC's quantum computer to our global interconnection ecosystem on Platform Equinix underpins our commitment to supporting innovation. We are looking forward to working together to solve some of the key digital challenges organizations face today."
(Source – Cision PR Newswire)
About Oxford Quantum Circuits
Founded in 2017, Oxford Quantum Circuits is an industry-leading quantum computing company. It makes quantum accessible to their clients, allowing them to conduct ground-breaking research. The company produced the only commercially available quantum computers in the United Kingdom. It introduced the first quantum computing as a service (QCaaS) in the United Kingdom, making quantum technology accessible to businesses.
Read More
APPLICATION INFRASTRUCTURE
Simulations Plus | January 16, 2023
Simulations Plus, Inc. recently announced that its DILIsym Services (DSS) division released DILIsym® version X (DSX) Beta, the latest iteration of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI).
DILIsym modeling aids vital drug development decisions by prevising the potential DILI risk of new drug candidates. The modeling also identifies the biochemical events that contribute to DILI caused by a medicine and can thus predict specific subgroups of patients who are more likely to get DILI from that drug.
DILIsym modeling information helps guide go/no-go decisions on big drug development projects, potentially averting the terrible financial impacts of failed clinical trials or better offering reassurance that DILI will not be an insurmountable barrier to FDA approval. Over the past 12 years, the DILIsym Services division has coordinated the DILI-sim Initiative, a public-private partnership that helped guide the development of the DILIsym software package.
Some of the substantial updates for DSX include:
A complete software redesign that includes command line and graphical interface options and server/cloud computing capability (HPGL)
Four new exemplar compounds included with varying clinical presentations:
PF-04895162 (Generaux 2019)
Efavirenz
Anastrozole
Tamoxifen
Two new SimCohorts that include variability in susceptibility to liver injury and biomarker-related parameters (ALT and bilirubin)
About Simulations Plus
Simulations Plus, Inc. is a leading drug discovery/development software developer and preclinical and clinical pharmacometric consulting services provider for regulatory submissions and quantitative systems pharmacology models for drug-induced liver, kidney, and nonalcoholic fatty liver disease. Its software is licensed and applied to drug research by major pharmaceutical, biotechnology, chemical, and consumer goods companies as well as regulatory agencies worldwide. With its subsidiaries, Cognigen, DILIsym Services, and Lixoft, Simulations Plus offers solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches.
Read More